Ultragenyx Pharmaceutical Inc. buy Barclays PLC
Start price
06.08.24
/
50%
€45.20
Target price
06.08.25
€74.24
Performance (%)
-0.89%
Price
07.08.24
€44.20
Summary
This prediction is currently active. Since the start of the prediction for Ultragenyx Pharmaceutical Inc. the price has only changed by -0.89%. This prediction currently runs until 06.08.25. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Ultragenyx Pharmaceutical Inc. | -0.89% |
iShares Core DAX® | -5.630% |
iShares Nasdaq 100 | -8.559% |
iShares Nikkei 225® | -9.576% |
iShares S&P 500 | -6.631% |
Comments by Barclays_PLC for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) had its price target lowered by analysts at Barclays PLC from $83.00 to $81.00. They now have an "overweight" rating on the stock.
Ratings data for RARE provided by MarketBeat